24/7 Patient Assistance: 760-405-8205

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Richard Sagebiel is a pathologist in San Francisco, California. He has been practicing medicine for more than two decades. He is also an expert dermatologist. Dr. Sagebiel is a board-certified pathologist and dermatologist. He graduated from the Harvard Medical School and continued with an internship at the Harborview Medical Center and a residency stage in anatomic and clinical pathology at the Massachusetts General Hospital. Dr. Richard Sagebiel is an active figure in the medical research field. He contributed to multiple publications that focused on topics like PHIP copy number in melanoma, cancer prognostic predictions, melanoma progression, melanoma risks related to sunbeds and sunlamps, identification of patients at melanoma risk, gene expression signatures, primary liver carcinoma, melanoma variants, Kaposi’s sarcoma, hereditary neurofibromas. Dr. Sagebiel currently works for the California Pacific Medical Center.


    Insurance Accepted

    AetnaFirst Health PPO


  • Education & Training

    dept_icon

    Harvard

    Medical School

    dept_icon

    Harborview Medical Center

    Internship

    dept_icon

    Massachusetts General Hospital

    Residency

  • Board Certifications

    American Board of Pathology

  • Hospital & Practice

    California Pacific Medical Center

    Languages: English/Spanish

    (415) 600-6000

    Castro St & Duboce Ave

    San Francisco, California 94114

    Read More
  • Publications & Memberships

    Dr. Richard Sagebiel has contributed to 3 publications.

    Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration.

    Bezrookove, V.,De Semir, D.,Nosrati, M.,Tong, S.,Wu, C.,Thummala, S.,Dar, A. A.,Leong, S. P.,Cleaver, J. E.,Sagebiel, R. W.,Miller, J. R.,Kashani-Sabet, M.; J. Invest. Dermatol.. 2013 Sep 4.

    See more >>

    A patient-centered methodology that improves the accuracy of prognostic predictions in cancer.

    Kashani-Sabet, M.,Sagebiel, R. W.,Joensuu, H.,Miller, J. R.; PLoS ONE. 2013.

    See more >>

    The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression.

    Dar, A. A.,Majid, S.,Rittsteuer, C.,de Semir, D.,Bezrookove, V.,Tong, S.,Nosrati, M.,Sagebiel, R.,Miller, J. R.,Kashani-Sabet, M.; J Natl Cancer Inst. 2013 Mar 20.

    See more >>